Target intelligence / Profile preview

Zinc finger protein ZIC2 (ZIC2)

Target
ZIC2
Molecular classification
Transcription factor, C2H2-type zinc finger protein
01

Overview

Zinc finger protein ZIC2 (ZIC2) is a transcription factor of the ZIC family characterized by five C2H2-type zinc finger domains that enable binding to DNA and regulatory proteins[1][6][7]. It is critically involved in embryonic brain development, including patterning of the forebrain, neural tube closure, formation of the left-right body axis, and retinal axon guidance[1][4][5]. ZIC2 modulates gene expression primarily through transcriptional repression, acting at enhancer regions, and functions in chromatin remodeling and regulation of embryonic stem cell fate by interacting with the NuRD complex[2][3]. Mutations in ZIC2 cause holoprosencephaly type 5 and are associated with neural tube defects and various midline developmental anomalies[1][4][7]. Overexpression of ZIC2 has been linked with tumorigenesis, cancer progression, and poor prognosis in several malignancies, and abnormal ZIC2 activity impacts immune regulation and genomic stability[6]. No drugs are currently known to directly target ZIC2.

Other names
Zinc finger protein of the cerebellum 2HPE5Zic family member 2 (odd-paired homolog, Drosophila)Zinc finger protein ZIC 2ZIC2Zic2
02

Biological functions

Regulation of embryonic development, especially forebrain and neural tube patterningTranscriptional repression and activation via DNA bindingRegulation of enhancer activity in embryonic stem cellsCell differentiation in early embryogenesisAxon guidance in neuronal developmentRegulation of left-right axis formation
03

Disease associations

Congenital brain malformation (holoprosencephaly, neural tube defects)Cancer (overexpression linked to tumor progression and poor prognosis in some cancers)Retinal and craniofacial developmental defects
04

Safety considerations

Mutations or altered dosage can cause severe congenital anomalies (e.g., holoprosencephaly, neural tube defects)Potential cancer progression if aberrantly expressed
05

Biomarkers

Prognostic marker for certain cancers (expression levels associated with tumor progression and immune characteristics)Genetic marker for risk of holoprosencephaly and neural tube defects

Beyond the preview

Go deeper on Zinc finger protein ZIC2 (ZIC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein ZIC2 (ZIC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call